The PassMachine Consultation-Liaison Psychiatry Board Review 2020
YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT
‘‘Here’s the challenge: this Consultation-Liaison Psychiatry review features 50.5 hours of laser-focused lectures and 900+ Q Bank questions, but all that great content means nothing if you don’t get through it in time for the exam. So, Beat The Boards! makes your prep easy
Intended Audience: Psychiatrists
Learning Objectives:
Upon completion of this program, participants should be able to conduct, discuss, and describe:
– Assessment and screening of eating and feeding disorders
– Assessment and management of psychosomatic aspects of select heart diseases and psychiatric syndromes in heart disease
– Management of substance-related and addictive disorders
– Normal sexual function and age-related changes, general assessment and management approaches for sexual dysfunctions, gender dysphoria, paraphilic disorders
Topics And Speakers:
– 01A Psychiatric Disorders in Chronic Kidney Disease I
– 01B Psychiatric Disorders in Chronic Kidney Disease II
– 01C Psychiatric Disorders in Chronic Kidney Disease III
– 02A Neurology I- Cortical Syndromes
– 02B Neurology II- Movement Disorders & Stroke
– 02C Neurology III- Seizures & Headaches
– 03A Endocrine I- Diabetes Mellitus
– 03B Endocrine II- Thyroid and Parathyroid Diseases
– 03C Endocrine III- Parathyroid and Adrenal Diseases, Pheochromocytoma, and Osteoporosis
– 03D Endocrine IV- Assessment and Management of Psychosomatic Aspects of Select Endocrine Diseases
– 04A Surgery and Surgical Critical Care I- Role of Psychiatrist and Preoperative Psychiatric Evaluations
– 04B Surgery and Surgical Critical Care II- Preoperative and Perioperative Issues
– 04C Surgery and Surgical Critical Care III- Postoperative Issues, Management of Psychiatric Disorders on Surgical and Intensive Care Units, ICU Delirium, and Burn Patients
– 05A Obstetrics and Gynecology I- Introduction to Obstetrics and Gynecology and Psychiatric Comorbidities in OB_GYN Diseases
– 05B Obstetrics and Gynecology II- Assessment and Management of Psychosomatic Aspects of Select OB_GYN Conditions
– 05C Obstetrics and Gynecology III- Assessment and Management of Psychosomatic Aspects of Select OB_GYN Conditions
– 06 Rheumatology
– 07A Dermatology I- General Assessment Approaches, General Management Approaches, and Dermatologic Manifestations of Psychiatric Disorders
– 07B Dermatology II- Psychological Factors in Dermatologic Diseases and in Their Treatment, Factitious Disorders, and Prescribing Guidelines
– 08A Heart I- Assessment and Management of Psychosomatic Aspects of Select Heart Diseases and Psychiatric Syndromes in Heart Disease
– 08B Heart II- Psychological Factors in Heart Disease and its Treatment and Psychiatric Assessment in the Context of Heart Disease
– 08C Heart III- Psychiatric Management in the Context of Heart Disease and Prescribing Guidelines
– 09A Pain I- Introduction, Epidemiology of Pain Conditions and Scope of Pain-killer Epidemic, Neurobiology, Cognitive and Emotional Factors
– 09B Pain II- Pain Assessment_Pain Scales and Assessment and Management of Psychosomatic Aspects of Select Pain Conditions
– 09C Pain III- Psychiatric Comorbidities and Differential Diagnoses, Pharmacologic and Other Somatic Interventions, Psychosocial Treatment Interventions, and Other Topics
– 10A Transplant Psychiatry I- Pre-transplant Evaluation
– 10B Transplant Psychiatry II- Post-transplant Management
– 11A Palliative Medicine I- Introduction to Palliative Medicine and Managing Psychiatric Disorders in the Palliative Setting
– 11B Palliative Medicine II- Psychological Interventions, Spirituality, Working with Families, Interdisciplinary Issues, Grief, Grief Therapy, and Bereavement
– 12A Pulmonary Disorders I- Assessment and Management of Psychosomatic Aspects of Select Pulmonary Diseases
– 12B Pulmonary Disorders II- Assessment and Management of Psychosomatic Aspects of Select Pulmonary Diseases
– 12C Pulmonary Disorders III- Psychiatric Assessment and Management in the Context of Pulmonary Disease
– 13A Gastrointestinal Disorders I- Assessment and Management of Select GI Syndromes
– 13B Gastrointestinal Disorders II- Hepatitis, Drug Induced Liver Disease and Liver Transplantation
– 13C Gastrointestinal Disorders III- Pancreatic Disorders, Psychiatric Management in Liver Disease and Psychological Factors in GI Diseases
– 14A Legal Issues- Part I
– 14B Legal Issues- Part II
– 15 Ethics and Practice Issues
– 16A Psychoncology I- Psychiatric Syndromes Present in Cancer, Psychological Factors in Cancer and in its treatment, and Psychiatric Assessment
– 16B Psychoncology II- Psychiatric Management in the Context of Cancer, Medication Use and Adverse Effects in Context of Cancer and Psychiatric Morbidity
– 17A Pediatric Psychiatry I- General Psychiatric Assessment and Management Approaches
– 17B Pediatric Psychiatry II- Assessment and Management of Psychosomatic Aspects of Select Pediatric Conditions and Prescribing Guidelines- Psychiatric Management In Context of Neurologic Diseases
– 18A Psychosomatic Topics in Physical Medicine and Rehabilitation I- Introduction, Traumatic Brain Injury, and Principles of Cognitive Rehabilitation
– 18B Psychosomatic Topics in Physical Medicine and Rehabilitation II- Spinal Cord Injury, Paralysis, and Neuromuscular Condition
– 19 Special Topics for the Psychosomatic Medicine Course
– 20A Hematology I
– 20B Hematology II
– 21A HIV_AIDS I- Basic Pathophysiology, Diagnosis, and Assessment
– 21B HIV_AIDS II- Psychiatric Management
– 21C HIV_AIDS III- Relevant Psychological Factors and Pharmacologic Issues
– 22A Chronic Fatigue Syndrome I- Basic Pathophysiology, Diagnosis, and Assessment
– 22B Chronic Fatigue Syndrome II- Relevant Psychological Factors, Psychiatric Management, and Pharmacologic Issues
– 23 Fibromyalgia Syndrome
– 24A Assessment I- Consultation Overview, Cultural and Spiritual Issues
– 24B Assessment II- Neuroimaging
– 24C Assessment III- Neuropsychological Testing
– 25A Delirium- Part I
– 25B Delirium- Part II
– 26A Neurocognitive Disorders I- Diagnostic Criteria and Classification
– 26B Neurocognitive Disorders II- Diagnostic Assessment
– 26C Neurocognitive Disorders III- General Management
– 26D Neurocognitive Disorders IV- Review of Alzheimer’s Disease
– 26E Neurocognitive Disorders V- Review of Lewy Body and Vascular Disease
– 26F Neurocognitive Disorders VI- Review of Frontal Temporal NCD and Infectious Diseases
– 26G Neurocognitive Disorders VII- Review of Other Etiologies
– 27 Psychological Reactions to Illness
– 28A Depressive Disorders 1- Clinical Overview & Pathophysiology
– 28B Depressive Disorders 2- Diagnosis and Assessment
– 28C Depressive Disorders 3- Treatment Overview and SSRIs _SNRIs
– 28D Depressive Disorders 4- Antidepressants and ECT
– 28E Depressive Disorders 5- Somatic Treatments and Psychotherapies
– 29A Bipolar Disorders I- Bipolar Disorder Diagnosis, Assessment of Bipolar Disorders and Secondary Bipolar Disorders
– 29B Bipolar Disorders II- Bipolar Disorders in Specific Medical Populations and Management of Bipolar Disorders
– 30A Suicide
– 30B Violence and Aggression
– 31A Schizophrenia Spectrum Disorders and Psychosis I- Epidemiology and Etiologies of Psychosis
– 31B Schizophrenia Spectrum Disorders and Psychosis II- Assessment in the Medically Ill and Psychosis in Specific Medical Populations
– 31C Schizophrenia Spectrum Disorders and Psychosis III- Review of Catatonic Syndrome and Catatonic Syndrome in Specific Medical Populations
– 31D Schizophrenia Spectrum Disorders and Psychosis IV- Review of Specific Schizophrenia Spectrum Disorders and Specific Management Considerations of Psychosis in the Medically Ill
– 32A Anxiety Disorders I- Anxiety Mechanisms and Evaluation
– 32B Anxiety Disorders II- Review of Specific Anxiety Disorders
– 32C Anxiety Disorders III- Secondary Anxiety Disorders
– 32D Anxiety Disorders IV- Anxiety Presentations in Specific Medical Populations
– 32E Anxiety Disorders V- Management of Anxiety
– 32F Anxiety Disorders VI- Post Traumatic Stress Disorder
– 33A Somatic Symptom and Related Disorders
– 33B Factitious Disorder and Malingering
– 34A Eating and Feeding Disorders I- Overview of Eating and Feeding Disorders and Assessment and Screening
– 34B Eating and Feeding Disorders II- Review of Specific Eating and Feeding Disorders- Diagnostic and Clinical Presentations, Epidemiology and Etiologies, Assessment and Management
– 34C Eating and Feeding Disorders III- Specific Eating & Feeding Disorders- Diagnostic & Clinical Presentations, Epidemiology & Etiologies, Assessment & Management and Eating
– 35A Sleep-Wake Disorders I
– 35B Sleep-Wake Disorders II
– 36A Sexual Dysfunctions, Gender Dysphoria, Paraphilic Disorders I- Normal Sexual Function and Age-Related Changes, General Assessment Approaches and General Management Approaches
– 36B Sexual Dysfunctions, Gender Dysphoria, Paraphilic Disorders II- Specific Sexual Dysfunction Disorders, Specific Medical Populations, Gender Dysphoria and Paraphilic Disorders
– 37A Substance-related and Addictive Disorders I- Overview of Substance Related Disorders and Assessment in the Medically Ill
– 37B Substance-related and Addictive Disorders II- Review of Alcohol Sedative Use Disorders
– 37C Substance-related and Addictive Disorders III- Review of Opioid Use Disorders and Review of Stimulant Use Disorders
– 37D Substance-related and Addictive Disorders IV- Nicotine Use Disorders, Cannabis Use Disorders, Other Drugs of Abuse and Impaired Health Care Providers
– 38A Psychopharmacology I- Pharmacokinetics
– 38B Psychopharmacology II- Pharmacodynamics
– 38C Psychopharmacology III- Adverse Drug Reactions and Pregnancy-Related Issues
– 38D Psychopharmacology IV- Prescribing Cautions and Drug-Drug Interactions
Related products
